PHARMACOLOGIC DATA AND TECHNICAL FEASIBILITY OF INTRAPERITONEAL DOXORUBICIN ADMINISTRATION

被引:13
作者
DEMICHELI, R
BONCIARELLI, G
JIRILLO, A
FORONI, R
PETROSINO, L
TARGA, L
GARUSI, G
机构
[1] USSL 28,SERV EMODIALISI,I-37045 LEGNAGO,ITALY
[2] USSL 28,SERV ANALISI CHIM CLINCHE,I-37045 LEGNAGO,ITALY
关键词
D O I
10.1177/030089168507100112
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:63 / 68
页数:6
相关论文
共 18 条
[1]  
BENJAMIN RS, 1977, CANCER RES, V37, P1416
[2]  
CASPER ES, 1983, CANCER TREAT REP, V67, P235
[3]  
CHANG P, 1976, CLIN PHARMACOL THER, V20, P611
[4]  
CLARKSON B, 1964, CLIN PHARMACOL THER, V5, P581
[5]  
DEDRICK RL, 1978, CANCER TREAT REP, V62, P1
[6]  
DEDRICK RL, 1982, ASAIO J, V5, P1
[7]   PHARMACOLOGICAL DATA AND TECHNICAL FEASIBILITY OF INTRAPERITONEAL 5-FLUOROURACIL ADMINISTRATION [J].
DEMICHELI, R ;
JIRILLO, A ;
BONCIARELLI, G ;
BELLINI, A ;
PETROSINO, L ;
BIGI, L ;
GARUSI, GF .
TUMORI, 1982, 68 (05) :437-441
[8]  
GREEN T, 1959, OBSTET GYNECOL, V64, P383
[9]  
JONES RB, 1981, CANCER RES, V41, P55
[10]  
KOTTMEIER H L, 1968, Clinical Obstetrics and Gynecology, V11, P428